Literature DB >> 3928701

Immune abnormalities in myelodysplastic syndromes.

T Economopoulos, J Economidou, G Giannopoulos, C Terzoglou, E Papageorgiou, J Dervenoulas, P Arseni, J Hadjioannou, S Raptis.   

Abstract

The immune states of 52 patients with myelodysplastic syndromes classified according to the FAB criteria were studied. Serum electrophoresis and immunoelectrophoresis, direct Coombs test, and tests for organ and non-organ specific antibodies were performed. Twenty six patients had immunoglobulin abnormalities: six (11.5%) had monoclonal gammopathy; 17 (32.6%) had polyclonal increases in serum immunoglobulin; while in three (5.8%) immunoglobulin concentrations were decreased. The distribution of immunoglobulin abnormalities among the five myelodysplastic syndrome subtypes was fairly uniform. Results of direct Coombs test were negative in all cases. Organ specific antibodies were not detected in any of the patients tested, although two patients were found positive for antinuclear antibodies. The presence of immunoglobulin abnormalities indicates an involvement of the lymphoplasmatic system in myelodysplastic syndromes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928701      PMCID: PMC499393          DOI: 10.1136/jcp.38.8.908

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Immunofixation. III. Application to the study of monoclonal proteins.

Authors:  R F Ritchie; R Smith
Journal:  Clin Chem       Date:  1976-12       Impact factor: 8.327

2.  Autoimmune phenomena in pernicious anaemia: gastric antibodies.

Authors:  K B TAYLOR; I M ROITT; D DONIACH; K G COUCHMAN; C SHAPLAND
Journal:  Br Med J       Date:  1962-11-24

3.  Immune complexes in myelofibrosis: a possible guide to management.

Authors:  C M Lewis; G D Pegrum
Journal:  Br J Haematol       Date:  1978-06       Impact factor: 6.998

4.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

Authors:  U Axelsson; R Bachmann; J Hällén
Journal:  Acta Med Scand       Date:  1966-02

5.  Immunological studies in an epidemic of infective, short-incubation hepatitis.

Authors:  A B Ajdukiewicz; R A Fox; F J Dudley; D Doniach; S Sherlock
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

6.  A new observation in the clinical spectrums of erythroleukemia. A report of 46 cases.

Authors:  P Hetzel; T S Gee
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

7.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.

Authors:  P J Fialkow; A M Denman; R J Jacobson; M N Lowenthal
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.

Authors:  R A Kyle; S Finkelstein; L R Elveback; L T Kurland
Journal:  Blood       Date:  1972-11       Impact factor: 22.113

9.  An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases.

Authors:  I Cayzer; S R Chalmers; D Doniach; G Swana
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

10.  The frequency of M-components in sera of patients with solid malignant neoplasms.

Authors:  A Talerman; W G Haije
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640

View more
  9 in total

1.  Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.

Authors:  R J Sokol; S Hewitt; D J Booker
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

2.  Monoclonal gammopathy in chronic myeloproliferative disorders.

Authors:  T Economopoulos; J Economidou; E Papageorgiou; J Dervenoulas; C Christodoulides; V Pappa; D Karakassis; C Terzoglou; S Athanassiadou; G Chalevelakis
Journal:  Blut       Date:  1989-01

3.  Immunological abnormalities in myelodysplastic syndrome.

Authors:  B Seitanides; A Antonopoulou; A Karabelis
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

4.  Sacroiliitis as an initial manifestation of acute myelogenous leukemia.

Authors:  Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

5.  Polychondritis Terminating in Eosinophilic Leukemia.

Authors:  Judit Várkonyi; Lajos Jakab; Attila Zalatnay; Péter Nagy; Rita Vámoss; Tamás Szombathy
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

6.  Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.

Authors:  T Shirota; O Hayashi; H Uchida; N Tonozuka; N Sakai; H Itoh
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

7.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

8.  Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.

Authors:  O Iwase; S Aizawa; Y Kuriyama; M Yaguchi; M Nakano; K Toyama
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

9.  B cell-activating factors in autoimmune pulmonary alveolar proteinosis.

Authors:  Masaki Hirose; Toru Arai; Chikatoshi Sugimoto; Takayuki Takimoto; Reiko Sugawara; Shojiro Minomo; Sayoko Shintani; Naoko Takeuchi; Kanako Katayama; Yasushi Inoue; Tomoko Kagawa; Takahiko Kasai; Masanori Akira; Yoshikazu Inoue
Journal:  Orphanet J Rare Dis       Date:  2021-03-02       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.